What the study found
The Boone-Mayer Scoring System appears to be a sound proposal for standardizing severity scoring in murine models of inflammatory bowel disease (IBD, a group of long-term intestinal diseases) across pre-clinical laboratories.
Why the authors say this matters
The study suggests that a standardized scoring system could help align how different pre-clinical IBD laboratories measure disease severity.
What the researchers tested
The article proposes the Boone-Mayer Scoring System as a scoring equation for murine (mouse) models of colitis, which is inflammation of the colon. The abstract does not provide further methodological details.
What worked and what didn't
The abstract states that the Boone-Mayer Scoring System appears to be a sound proposal for standardizing severity scoring. It does not report comparative testing, specific performance measures, or outcomes that did not work.
What to keep in mind
The available summary is very brief and does not describe the study design, data, or validation results in detail. Limitations are not otherwise described in the abstract.
Key points
- The Boone-Mayer Scoring System is presented as a proposal for standardizing severity scoring in murine models of IBD.
- The abstract says the proposal appears to be sound.
- The authors frame the work as relevant to pre-clinical IBD laboratories.
- The abstract refers to murine models of colitis, meaning mouse models of colon inflammation.
- No detailed methods, validation results, or limitations are provided in the abstract.
Disclosure
- Research title:
- Boone-Mayer scoring system proposed for murine colitis standardization
- Publication date:
- 2026-03-08
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.